Skip to main content
TipRanks
Go Ultimate75% OFF

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Stock Statistics & Valuation Metrics

9 Followers

Total Valuation

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has a market cap or net worth of HKD 371.11B. The enterprise value is HKD 281.48B.

Market Cap
HKD 371.11B
Enterprise Value
HKD 281.48B

Share Statistics

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has 258,197,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
258,197,600
Owned by Insiders
―
Owned by Institutions
22.14%

Financial Efficiency

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 12.55%.

Return on Equity (ROE)
0.13
Return on Assets (ROA)
0.11
Return on Invested Capital (ROIC)
12.55%
Return on Capital Employed (ROCE)
0.14
Revenue Per Employee
1.71M
Profits Per Employee
416.39K
Employee Count
20,602
Asset Turnover
0.45
Inventory Turnover
1.52

Valuation Ratios

The current PE Ratio of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H is 35.61. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s PEG ratio is 2.31.

PE Ratio
35.61
PS Ratio
9.33
PB Ratio
4.75
Price to FCF
50.21
Price to Operating Cash Flow
31.65
PEG Ratio
2.31

Income Statement

In the last 12 months, Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H had revenue of 35.19B and earned 8.58B in profits. Earnings per share was 1.32.

Revenue
35.19B
Gross Profit
30.33B
Operating Income
10.00B
Pretax Income
9.69B
Net Income
8.58B
EBITDA
10.63B
Earnings Per Share (EPS)
1.32

Cash Flow

In the last 12 months, operating cash flow was 11.56B and capital expenditures -4.48B, giving a free cash flow of 7.08B billion.

Operating Cash Flow
11.56B
Free Cash Flow
7.08B
Free Cash Flow per Share
0.93

Dividends & Yields

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H pays an annual dividend of HKD 0.23, resulting in a dividend yield of 0.46%

Dividend Per Share
HKD 0.23
Dividend Yield
0.46%
Payout Ratio
16.52%
Free Cash Flow Yield
1.99%
Earnings Yield
2.80%

Stock Price Statistics

Beta
0.53
52-Week Price Change
-32.11%
50-Day Moving Average
47.98
200-Day Moving Average
57.46
Relative Strength Index (RSI)
49.18
Average Volume (3m)
5.14M

Important Dates

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H upcoming earnings date is Apr 19, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 27, 2026
Next Earnings Date
Apr 19, 2027
Ex-Dividend Date
Apr 29, 2026

Financial Position

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H as a current ratio of 8.08, with Debt / Equity ratio of 0.07%

Current Ratio
8.08
Quick Ratio
7.63
Debt to Market Cap
0.00
Net Debt to EBITDA
-4.28
Interest Coverage Ratio
626.53

Taxes

In the past 12 months, Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has paid 1.10B in taxes.

Income Tax
1.10B
Effective Tax Rate
0.11

Enterprise Valuation

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H EV to EBITDA ratio is 26.99, with an EV/FCF ratio of 43.17.

EV to Sales
8.02
EV to EBITDA
26.99
EV to Free Cash Flow
43.17
EV to Operating Cash Flow
26.30

Balance Sheet

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has HKD 50.97B in cash and marketable securities with HKD 493.42M in debt, giving a net cash position of HKD 50.48B billion.

Cash & Marketable Securities
HKD 50.97B
Total Debt
HKD 493.42M
Net Cash
HKD 50.48B
Net Cash Per Share
HKD 195.51
Tangible Book Value Per Share
HKD 10.39

Margins

Gross margin is 85.93%, with operating margin of 27.43%, and net profit margin of 27.04%.

Gross Margin
85.93%
Operating Margin
27.43%
Pretax Margin
30.52%
Net Profit Margin
27.04%
EBITDA Margin
29.73%
EBIT Margin
28.18%

Analyst Forecast

The average price target for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H is HKD 81.55, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
HKD 81.55
Price Target Upside
65.35% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
11.35%
EPS Growth Forecast
21.43%

Scores

Smart Score
6
AI Score
71